Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Arid1a Loss Drives Nonalcoholic Steatohepatitis in Mice Through Epigenetic Dysregulation of Hepatic Lipogenesis and Fatty Acid Oxidation.
Journal: Hepatology (Baltimore, Md.)
Published: April 04, 2018
Disease-modifying effects of orally bioavailable NF-κB inhibitors in dystrophin-deficient muscle.
Journal: JCI insight
Published: December 27, 2016
A Novel NF-κB Inhibitor, Edasalonexent (CAT-1004), in Development as a Disease-Modifying Treatment for Patients With Duchenne Muscular Dystrophy: Phase 1 Safety, Pharmacokinetics, and Pharmacodynamics in Adult Subjects.
Journal: Journal of clinical pharmacology
Published: August 24, 2016
Synthesis and Characterization of Fatty Acid Conjugates of Niacin and Salicylic Acid.
Journal: Journal of medicinal chemistry
Published: January 20, 2016
Showing 1-4 of 4
Last Updated: 09/26/2026